Similar articles

• Mu-, delta-, kappa-opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments.

  Fowler CJ, Fraser GL. Fowler CJ, et al. Neurochem Int. 1994 May;24(5):401-26. doi: 10.1016/0197-0186(94)90089-2. Neurochem Int. 1994. PMID: 7647696 Review.
• [The opiate system in the regulation of central hemodynamics].

  Lishmanov IuB, Maslov LN. Lishmanov IuB, et al. Patol Fiziol Eksp Ter. 2003 Jan-Mar;(1):2-11. Patol Fiziol Eksp Ter. 2003. PMID: 12652936 Review. Russian. No abstract available.
• Opioid receptors and their subtypes: focus on peripheral isolated tissue preparations.

  Traynor JR. Traynor JR. Neurochem Int. 1994 May;24(5):427-32. doi: 10.1016/0197-0186(94)90090-6. Neurochem Int. 1994. PMID: 7647697 Review. No abstract available.
• Molecular biology of opioid receptors: recent advances.

  Singh VK, Bajpai K, Biswas S, Haq W, Khan MY, Mathur KB. Singh VK, et al. Neuroimmunomodulation. 1997 Sep-Dec;4(5-6):285-97. doi: 10.1159/000097349. Neuroimmunomodulation. 1997. PMID: 9650823 Review.
• [Use of opiate receptor antagonists and peptidase inhibitors for studying central morphinomimetic peptidergic systems].

  Malfroy B. Malfroy B. Ann Endocrinol (Paris). 1983;44(5):335-7. Ann Endocrinol (Paris). 1983. PMID: 6326657 French. No abstract available.